ANAPTYSBIO INC's ticker is ANAB and the CUSIP is 032724106. A total of 121 filers reported holding ANAPTYSBIO INC in Q4 2019. The put-call ratio across all filers is 1.41 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2019 | $920,000 | -53.6% | 56,602 | -0.0% | 0.01% | -60.0% |
Q3 2019 | $1,981,000 | -38.0% | 56,604 | +0.0% | 0.02% | -37.5% |
Q2 2019 | $3,193,000 | -61.2% | 56,602 | -49.8% | 0.02% | -64.7% |
Q1 2019 | $8,233,000 | +5.2% | 112,700 | -8.1% | 0.07% | -11.7% |
Q4 2018 | $7,827,000 | +1917.3% | 122,700 | +3189.5% | 0.08% | +1440.0% |
Q1 2018 | $388,000 | – | 3,730 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TANG CAPITAL MANAGEMENT LLC | 1,950,609 | $35,032,938 | 4.94% |
EcoR1 Capital, LLC | 7,521,024 | $135,077,591 | 4.56% |
Saturn V Capital Management LP | 577,101 | $10,364,734 | 4.34% |
GREAT POINT PARTNERS LLC | 894,333 | $16,062,221 | 2.93% |
5AM Venture Management, LLC | 357,733 | $6,424,885 | 1.85% |
First Light Asset Management, LLC | 790,806 | $14,202,876 | 1.35% |
Boxer Capital, LLC | 1,300,000 | $23,348,000 | 1.24% |
Frazier Life Sciences Management, L.P. | 899,700 | $16,158,612 | 1.07% |
Deep Track Capital, LP | 1,345,813 | $24,170,801 | 0.93% |
Palo Alto Investors LP | 431,224 | $7,744,783 | 0.73% |